Successful treatment of hyperglycemia with liraglutide in a hospitalized 27-year-old patient with schizophrenia: A case report

Table 1 Changes in clinical indicators during treatment

	Hospital admission1	Hospital discharge2	Follow-up3
Height (cm)	166	166	166
Weight (kg)	106.3	104	98.4
BMI (kg/m2)	38.58	37.74	35.71
Blood pressure (mmHg)	130/80	122/78	120/80
Pulse rate (times/min)	80	78	78
Blood glucose (mmol/L)	15.0	4.9	5.07
HbA1c (%)	12.3	NA	6.0
Insulin (pmol/L)	733.10	NA	NA
Total bilirubin (μmol/L)	12.11	NA	4.93
Albumin (g/L)	45.1	NA	47.5
ALT (IU/L)	22	NA	26
AST (IU/L)	27	NA	26
Total cholesterol (mmol/L)	6.02	NA	5.00
Triglyceride (mmol/L)	1.81	1.7	1.62
Uric acid (μmol/L)	484	366	382
Creatinine (μmol/L)	70	NA	72
HDL (mmol/L)	1.20	NA	1.39
LDL (mmol/L)	3.48	3.21	2.29
Testosterone (nmol/L)	14.940	NA	NA
TSH (mIU/L)	1.770	NA	3.500
Serum potassium (mmol/L)	4.26	4.25	4.51
Urine free cortisol (nmol/24 h)	168.3	NA	NA
Fasting plasma cortisol (nmol/L)	254	NA	NA

¹Date of admission: December 20, 2019.

² Date of discharge: December 31, 2019.

³Date of follow-up: November 20, 2021.

BMI: Body mass index; ALT: Alanine transaminase; AST: Aspertate Aminotransferase; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; TSH: Thyroid stimulating hormone; NA: Unmeasured; HbA1c: Hemoglobin A1c.